188 related articles for article (PubMed ID: 25959002)
1. Psychological factors at early stage of treatment as predictors of receiving chemotherapy at the end of life.
Fujisawa D; Temel JS; Traeger L; Greer JA; Lennes IT; Mimura M; Pirl WF
Psychooncology; 2015 Dec; 24(12):1731-7. PubMed ID: 25959002
[TBL] [Abstract][Full Text] [Related]
2. Processes of discontinuing chemotherapy for metastatic non-small-cell lung cancer at the end of life.
Pirl WF; Greer JA; Irwin K; Lennes IT; Jackson VA; Park ER; Fujisawa D; Wright AA; Temel JS
J Oncol Pract; 2015 May; 11(3):e405-12. PubMed ID: 25829525
[TBL] [Abstract][Full Text] [Related]
3. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer.
Greer JA; Pirl WF; Jackson VA; Muzikansky A; Lennes IT; Heist RS; Gallagher ER; Temel JS
J Clin Oncol; 2012 Feb; 30(4):394-400. PubMed ID: 22203758
[TBL] [Abstract][Full Text] [Related]
4. Dying with cancer: patients' function, symptoms, and care preferences as death approaches.
McCarthy EP; Phillips RS; Zhong Z; Drews RE; Lynn J
J Am Geriatr Soc; 2000 May; 48(S1):S110-21. PubMed ID: 10809464
[TBL] [Abstract][Full Text] [Related]
5. Early palliative care for patients with metastatic non-small-cell lung cancer.
Temel JS; Greer JA; Muzikansky A; Gallagher ER; Admane S; Jackson VA; Dahlin CM; Blinderman CD; Jacobsen J; Pirl WF; Billings JA; Lynch TJ
N Engl J Med; 2010 Aug; 363(8):733-42. PubMed ID: 20818875
[TBL] [Abstract][Full Text] [Related]
6. Changes in and Determinants of Quality of Life in Patients With Advanced Non-Small-Cell Lung Cancer Undergoing Initial Chemotherapy.
Dai YL; Yang CT; Chen KH; Tang ST
J Nurs Res; 2017 Jun; 25(3):203-215. PubMed ID: 28481816
[TBL] [Abstract][Full Text] [Related]
7. Behavioral and psychological predictors of chemotherapy adherence in patients with advanced non-small cell lung cancer.
Greer JA; Pirl WF; Park ER; Lynch TJ; Temel JS
J Psychosom Res; 2008 Dec; 65(6):549-52. PubMed ID: 19027443
[TBL] [Abstract][Full Text] [Related]
8. Metastatic non-small cell lung cancer: a benchmark for quality end-of-life cancer care?
Philip J; Hudson P; Bostanci A; Street A; Horey DE; Aranda S; Zordan R; Rumbold BD; Moore G; Sundararajan V
Med J Aust; 2015 Feb; 202(3):139-43. PubMed ID: 25669476
[TBL] [Abstract][Full Text] [Related]
9. Age and Gender Moderate the Impact of Early Palliative Care in Metastatic Non-Small Cell Lung Cancer.
Nipp RD; Greer JA; El-Jawahri A; Traeger L; Gallagher ER; Park ER; Jackson VA; Pirl WF; Temel JS
Oncologist; 2016 Jan; 21(1):119-26. PubMed ID: 26621041
[TBL] [Abstract][Full Text] [Related]
10. Psychological well-being in advanced NSCLC patients in Serbia: impact of sociodemographic and clinical factors.
Maric DM; Jovanovic DM; Golubicic IV; Nagorni-Obradovic LJ; Stojsic JM; Pekmezovic TD
Neoplasma; 2010; 57(1):1-7. PubMed ID: 19895165
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia: A Randomized Clinical Trial.
El-Jawahri A; LeBlanc TW; Kavanaugh A; Webb JA; Jackson VA; Campbell TC; O'Connor N; Luger SM; Gafford E; Gustin J; Bhatnagar B; Walker AR; Fathi AT; Brunner AM; Hobbs GS; Nicholson S; Davis D; Addis H; Vaughn D; Horick N; Greer JA; Temel JS
JAMA Oncol; 2021 Feb; 7(2):238-245. PubMed ID: 33331857
[TBL] [Abstract][Full Text] [Related]
12. Effect of integrated palliative care on the quality of end-of-life care: retrospective analysis of 521 cancer patients.
Colombet I; Montheil V; Durand JP; Gillaizeau F; Niarra R; Jaeger C; Alexandre J; Goldwasser F; Vinant P
BMJ Support Palliat Care; 2012 Sep; 2(3):239-47. PubMed ID: 24654196
[TBL] [Abstract][Full Text] [Related]
13. Association of Early Palliative Care With Chemotherapy Intensity in Patients With Advanced Stage Lung Cancer: A National Cohort Study.
Lammers A; Slatore CG; Fromme EK; Vranas KC; Sullivan DR
J Thorac Oncol; 2019 Feb; 14(2):176-183. PubMed ID: 30336324
[TBL] [Abstract][Full Text] [Related]
14. Early palliative care and metastatic non-small cell lung cancer: potential mechanisms of prolonged survival.
Irwin KE; Greer JA; Khatib J; Temel JS; Pirl WF
Chron Respir Dis; 2013 Feb; 10(1):35-47. PubMed ID: 23355404
[TBL] [Abstract][Full Text] [Related]
15. Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data.
Hopwood P; Stephens RJ
J Clin Oncol; 2000 Feb; 18(4):893-903. PubMed ID: 10673533
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies.
Sheng J; Zhang YX; He XB; Fang WF; Yang YP; Lin GN; Wu X; Li N; Zhang J; Zhai LZ; Zhao YY; Huang Y; Zhou NN; Zhao HY; Zhang L
Oncologist; 2017 Jan; 22(1):53-60. PubMed ID: 27789776
[TBL] [Abstract][Full Text] [Related]
17. Palliative Chemotherapy Near the End of Life in Oncology Patients.
Zhang Z; Chen ML; Gu XL; Liu MH; Zhao WW; Cheng WW
Am J Hosp Palliat Care; 2018 Sep; 35(9):1215-1220. PubMed ID: 29529885
[TBL] [Abstract][Full Text] [Related]
18. Administration of chemotherapy with palliative intent in the last 30 days of life: the balance between palliation and chemotherapy.
Zdenkowski N; Cavenagh J; Ku YC; Bisquera A; Bonaventura A
Intern Med J; 2013 Nov; 43(11):1191-8. PubMed ID: 23870085
[TBL] [Abstract][Full Text] [Related]
19. The effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancer.
Dooms CA; Pat KE; Vansteenkiste JF
Expert Rev Anticancer Ther; 2006 Apr; 6(4):531-44. PubMed ID: 16613541
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study.
Belani CP; Brodowicz T; Ciuleanu TE; Krzakowski M; Yang SH; Franke F; Cucevic B; Madhavan J; Santoro A; Ramlau R; Liepa AM; Visseren-Grul C; Peterson P; John WJ; Zielinski CC
Lancet Oncol; 2012 Mar; 13(3):292-9. PubMed ID: 22336221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
